- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about LLY
Recent news which mentions LLY
Amgen's Rocatinlimab Has Commercial Potential Despite Competitive Landscape, Says Goldman Sachs
September 25, 2024
From Benzinga
Eli Lilly Touts Results Of EU-Approved Dermatitis Treatment, Shows Sustained Disease Control For Up To Three Years
September 25, 2024
From Benzinga
$1000 Invested In Eli Lilly 20 Years Ago Would Be Worth This Much Today
September 24, 2024
From Benzinga
Eli Lilly's Early Alzheimer's Treatment Donanemab Scores Japanese Approval, Its Second Largest Market
September 24, 2024
From Benzinga
Spotlight on Eli Lilly: Analyzing the Surge in Options Activity
September 23, 2024
Tickers
LLY
From Benzinga
Investing in This Healthcare Stock Could Be Like Catching Nvidia at the Dawn of the AI Boom
September 22, 2024
Tickers
LLY
From Motley Fool
Prediction: This Is What Eli Lilly Stock Will Do Next (Hint: It's Not a Stock Split)
September 21, 2024
Tickers
LLY
From Motley Fool
Why Novo Nordisk Stock Fell While Eli Lilly and Viking Therapeutics Bumped Higher Today
September 20, 2024
From Motley Fool
US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices
September 20, 2024
From Benzinga
In-Depth Analysis: Eli Lilly Versus Competitors In Pharmaceuticals Industry
September 20, 2024
From Benzinga
Eli Lilly Fights $183M Medicaid Fraud Judgment, Cites Reasonable Interpretation Of Medicaid Rules
September 20, 2024
From Benzinga
Why Tandem Diabetes Care Stock Thrashed the Market Today
September 19, 2024
From Motley Fool
1 Unstoppable Stock That Could Join the $1 Trillion Club in 2025
September 19, 2024
Tickers
LLY
From Motley Fool
Prediction: This Will be Eli Lilly's Next Big Move.
September 19, 2024
From Motley Fool
Why ResMed Stock Tumbled by 5% Today
September 18, 2024
From Motley Fool
Unpacking the Latest Options Trading Trends in Eli Lilly
September 17, 2024
Tickers
LLY
From Benzinga
Prediction: This Will Be the First Healthcare Stock to Join the Trillion-Dollar Club
September 17, 2024
Tickers
LLY
From Motley Fool
1 Telemedicine Stock I Wouldn't Touch With a 10-Foot Pole (Hint: It's Not Teladoc)
September 17, 2024
From Motley Fool
Eli Lilly Scores FDA Approval For Eczema Treatment Ebglyss
September 16, 2024
From Benzinga
3 Stocks to Buy and Hold Forever
September 14, 2024
From Motley Fool
Eli Lilly Pumps $800M Into Irish Operations To Meet Skyrocketing Demand For Mounjaro, Zepbound
September 12, 2024
From Benzinga
Unpacking the Latest Options Trading Trends in Eli Lilly
September 12, 2024
Tickers
LLY
From Benzinga
3 No-Brainer Biotech Stocks to Buy With $200 Right Now
September 12, 2024
From Motley Fool
Why Roche Holdings Stock Withered on Wednesday
September 11, 2024
From Motley Fool
Why Viking Therapeutics Stock Rocked the Market Today
September 11, 2024
From Motley Fool
4 No-Brainer Stock Splits to Buy Now
September 11, 2024
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.